US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

VYGR Voyager Therapeutics Inc

5.74

-0.17 (-2.88%)

27 Dic 2024 - Cerrado

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/23/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Eric Janiak, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robin E. Swartz

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Voyager Therapeutics (NASDAQ:VYGR)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024

Haga Click aquí para más Gráficas Voyager Therapeutics.

Voyager Therapeutics (NASDAQ:VYGR)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024

Haga Click aquí para más Gráficas Voyager Therapeutics.

Noticias sobre Voyager Therapeutics Inc VYGR

Form 4 - Statement of changes in beneficial ownership of securities
Jueves 26 de Diciembre 2024 (2 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 23 de Diciembre 2024 (5 días hace) • Edgar (US Regulatory)

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Miércoles 20 de Noviembre 2024 (1 mes hace) • GlobeNewswire Inc.

Voyager Reports Third Quarter 2024 Financial and Operating Results
Martes 12 de Noviembre 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Martes 12 de Noviembre 2024 (2 meses hace) • Edgar (US Regulatory)

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Miércoles 6 de Noviembre 2024 (2 meses hace) • GlobeNewswire Inc.

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Martes 5 de Noviembre 2024 (2 meses hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Jueves 3 de Octubre 2024 (3 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Miércoles 2 de Octubre 2024 (3 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 2 de Octubre 2024 (3 meses hace) • Edgar (US Regulatory)

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected
Lunes 16 de Septiembre 2024 (3 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Jueves 5 de Septiembre 2024 (4 meses hace) • Edgar (US Regulatory)

Más de Voyager Therapeutics Inc Artículos de Noticias

Invesco QQQ Trust Series 1

Financial Select Sector

Verizon Communications

Deutsche Telekom (QX)

Energy Select Sector SPDR

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones